Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 7, Issue 8, pp. 1293-1306
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 10, 2018
- Revision received March 6, 2019
- Accepted June 13, 2019
- Published first June 18, 2019.
Article Versions
- Previous version (June 18, 2019 - 08:41).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Megat Abd Hamid1,2,
- Ruo-Zheng Wang3,4,*,
- Xuan Yao1,2,
- Peiwen Fan3,4,
- Xi Li1,2,
- Xue-Mei Chang3,4,
- Yaning Feng3,4,
- Stephanie Jones5,
- David Maldonado-Perez5,6,
- Craig Waugh7,
- Clare Verrill5,6,
- Alison Simmons1,2,
- Vincenzo Cerundolo1,2,
- Andrew McMichael1,
- Christopher Conlon1,
- Xiyan Wang2,4,
- Yanchun Peng1,2, and
- Tao Dong1,2,3,*
- 1CAMS-Oxford International Centre for Translational Immunology, CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
- 2MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
- 3Chinese Academy of Medical Sciences (CAMS) Key Laboratory of Tumor Immunology and Radiation Therapy, Third Affiliated Hospital, Xinjiang Tumor Hospital, Urumqi, China.
- 4Third Affiliated Hospital, Xinjiang Tumor Hospital, Urumqi, China.
- 5Oxford Radcliffe Biobank, Department of Cellular Pathology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.
- 6Oxford NIHR Biomedical Research Centre, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
- 7Flow Cytometry Facility, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
- ↵*Corresponding Authors:
Tao Dong, University of Oxford, Oxford, Oxfordshire OX3 9DS, United Kingdom. Phone: 4418-6522-2401; Fax: 4418-6522-2502; E-mail: tao.dong{at}imm.ox.ac.uk; and Ruo-Zheng Wang, Third Affiliated Hospital, Xinjiang Tumor Hospital, Urumqi, China. E-mail: wrz8526{at}163.com
M. Abd Hamid, R.-Z. Wang, X. Yao, and P. Fan; Y. Peng and Tao Dong contributed equally to this article.
August 2019
Volume 7, Issue 8
Volume 7, Issue 8
Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses
Jump to section
Advertisement